Conference registration will remain open throughout the entirety of the conference.

Biocom’s Global Partnering & Investor Conference utilizes partneringONE to facilitate one-on-one meetings between conference attendees. Once the partnering system opens, approved registrants will be provided login credentials to start updating their profiles, identifying potential partners and requesting meetings with fellow attendees.

Our Global Partnering & Investor Conference will include multi-track presentation sessions, which provide a stage for emerging life science companies to showcase their latest innovations and gain additional exposure to investors and potential strategic partners in attendance. Applications to present are open through January 20.

Biocom California invites you to a welcome reception at The Lodge at Torrey Pines. This reception provides an excellent opportunity to network with conference attendees and speakers, as well as gain exclusive access to the delegates visiting San Diego from all over the globe.

We invite you to join us for a networking breakfast before our first session of the day. We encourage you to arrive by 8:00 a.m. to ensure you get a seat in time for the sessions kicking off at 8:15 a.m.

Conference registration will remain open throughout the entirety of the conference.

Biocom’s Global Partnering & Investor Conference utilizes partneringONE to facilitate one-on-one meetings between conference attendees. Once the partnering system opens, approved registrants will be provided login credentials to start updating their profiles, identifying potential partners and requesting meetings with fellow attendees.

Our Global Partnering & Investor Conference will include multi-track presentation sessions, which provide a stage for emerging life science companies to showcase their latest innovations and gain additional exposure to investors and potential strategic partners in attendance. Applications to present are open through January 20.

Our Global Partnering & Investor Conference will include multi-track presentation sessions, which provide a stage for emerging life science companies to showcase their latest innovations and gain additional exposure to investors and potential strategic partners in attendance. Applications to present are open through January 20.

Unwind from a day of enriching sessions and one-on-one partnering meetings while taking in the breathtaking views of the world-famous Torrey Pines Golf Course at our Gala Networking Reception on the outdoor lawn. Often hailed as the highlight of the conference, this evening reception promises great company, delicious bites and a fully hosted cocktail and mocktail bar ensuring everyone can raise a glass to success. Friendly Reminder: While San Diego is known for its great weather, please prepare to be outside as colder weather is anticipated.

Conference registration will remain open throughout the entirety of the conference.

We invite you to join us for a networking breakfast before our first session of the day. We encourage you to arrive by 8:00 a.m. to ensure you get a seat in time for the sessions kicking off at 8:15 a.m.

Biocom’s Global Partnering & Investor Conference utilizes partneringONE to facilitate one-on-one meetings between conference attendees. Once the partnering system opens, approved registrants will be provided login credentials to start updating their profiles, identifying potential partners and requesting meetings with fellow attendees.

We are proud to announce our keynote session, an unscripted discussion between former president of Lilly Research Laboratories, Steven Paul, M.D., and the research leaders of three major pharmaceutical powerhouses: Jay Bradner, M.D. (Amgen), Jonathon Sedgwick, Ph.D. (AbbVie), and Daniel Skovronsky, M.D., Ph.D. (Eli Lilly). This can’t-miss conversation will touch on the areas of innovation that are generating the greatest interest, the role of AI in accelerating drug discovery and development, how biotech companies can most effectively work with large pharmaceutical companies and more.

Jay Bradner, M.D.

Executive Vice President, Research & Development, Amgen

Steven Paul, M.D.

Board Chair, FNIH; Venture Partner, Third Rock Ventures

Jonathon Sedgwick, Ph.D.

Senior Vice Pre​sident & Global Head, Discovery Research, AbbVie

Daniel Skovronsky, M.D., Ph.D.

Chief Scientific & Product Officer; President, Lilly Research Laboratories, Eli Lilly

Join us for complimentary drinks and hors d’oeuvres immediately following the closing session of the conference. Don’t miss the opportunity to make those last connections with attendees and speakers before leaving sunny San Diego.